Issue Concerning Kratom’s Legality in the USA

Kratom is an “herbal opioid” drug that is considered a “schedule I drug” in the US as of August 2016. The product has a long back history coming from Africa and Southeast Asia that was used primarily for formalities. It came from a tropical sapling where the leaves are eaten to help reduce fatigue. It is a associate to the coffee household. It also help those that are in need of pain relief. Since it has become legal in the United States it has obtainable through capsules, liquids, crushed powder, and many more forms. However, the most common usage is brought through a tea, where consumer can ingest the opioid faster and more efficiently. Since it has become legal, it became an increasing trend in today’s market. There has been reports of the drug showing that it helps with emotional stability and helps with people’s nervous system. There also have been a few adverse effects on some people like dizziness, tremors, seizures, hence the controversy with its legality in the United States.

The DEA has put it into the “scheduled I drug” and from there is considered an “Eight Factor Test”, showing that the opioid could potentially be abused. Since they made that decision, the DEA has performed tests to see what that actual risks that are included with the legalities. They stated that it would need to be under a medical supervision while in use with subjects. The availability that people can get the drug are through smoke shops and all through the internet, but they also made it a point for it to be noted that the risk factors for the drug are shown to consumer as they are buying the opioid. The risks factors of overuse were significant.

Since the DEA made the decision to make it illegal in the United States, there have been petitions sent to take the drug off the market, but the general reaction was that the opioid did not retain the damage that the DEA first initially claimed it to hold. The public wanted to keep the drug on the market because it showed a reduction in pain and also the decrease in addiction. The general public also reported that the dug had many more benefits, so keeping the drug within reach was almost a necessity.Th ere was an additional letter that was drafted to the DEA from congress that would take the ban off the drug in October, 2016. Nevertheless, since then there has been no final decision that has been made to put the drug back on the market. The DEA is still doing tests for the future determination of the status on the drug. Therefore, due to the public reaction, the drug Kratom continues to control and regulate within the public.